News Archive

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM quoted Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology.

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. The Company develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden has three products currently on the market: Mevalone®, a foliar biofungicide that initially targets a key disease affecting grapes and other high-value crops; Cedroz™, a bionematicide that targets parasitic worms in high-value crops; and Ecovelex, which tackles crop destruction caused by birds. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites and harnessed by Eden's Sustaine® encapsulation technology.

Eden was included in the London Stock Exchange's 2026 Green Economy Mark cohort, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

The account will be led by Paul McManus, Managing Director, alongside Nick Rome, Director, and Anna Dunphy, Director. The team will manage the Company’s ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

For more information visit the Company’s website: https://www.edenresearch.com

Paul McManus, Founder and Managing Director of Walbrook PR, said: “We are delighted to be working with the Eden Research team as they continue to pursue their vision of becoming a global leader in sustainable crop protection. We look forward to supporting the Company as it builds on its strong foundations and continues to communicate its story to the City.”

For further information please contact:

Paul McManus

Tel: 020 7933 8780

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

 

About Walbrook PR:                                                                                              www.walbrookpr.com
Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM quoted companies.

Walbrook PR is ranked #2 in the AIM Adviser Rankings guide and is ranked in the top ten PR advisers by total number of Stock Market quoted clients. Walbrook acts for 30 listed companies (mainly AIM) across a wide mix of sectors and is the clear market leader by number of quoted companies in the Healthcare sector.

Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM quoted companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.